PGR and breast cancer: To measure whether hormonal signaling correlates with the circCD44/miR-502–5p axis, we treated MCF-7 and T47D ER/PR-positive breast cancer cells with estrone and Norgestimate (10 mol/L each) and detected the expression of circCD44 and miR-502–5p.